Treatment of recalcitrant erythrodermic psoriasis with ustekinumab

G. Stinco,A. Piccirillo,E. Errichetti,S. Bergamo,P. Patrone
DOI: https://doi.org/10.1684/ejd.2014.2325
2014-05-01
Abstract:Erythrodermic psoriasis (EP) can be challenging to treat since several factors, such as failure or intolerance, limit favourable outcomes with traditional therapies [1]. The conventional treatments recommended for EP are methotrexate, oral retinoids and cyclosporine [2], although systemic steroids are still used, especially in severe and unstable forms, since they usually induce a rapid clinical improvement [2, 3]. Recently, some cases of EP have been successfully treated with biological agents, [...]
What problem does this paper attempt to address?